NRXP
Price
$2.89
Change
+$0.22 (+8.24%)
Updated
Aug 15 closing price
Capitalization
56.36M
OSTX
Price
$2.06
Change
-$0.09 (-4.19%)
Updated
Aug 15 closing price
Capitalization
70.01M
One day until earnings call
Interact to see
Advertisement

NRXP vs OSTX

Header iconNRXP vs OSTX Comparison
Open Charts NRXP vs OSTXBanner chart's image
NRX Pharmaceuticals
Price$2.89
Change+$0.22 (+8.24%)
Volume$570.76K
Capitalization56.36M
OS Therapies
Price$2.06
Change-$0.09 (-4.19%)
Volume$487.22K
Capitalization70.01M
NRXP vs OSTX Comparison Chart in %
Loading...
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OSTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NRXP vs. OSTX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NRXP is a Hold and OSTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 17, 2025
Stock price -- (NRXP: $2.89 vs. OSTX: $2.06)
Brand notoriety: NRXP and OSTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NRXP: 245% vs. OSTX: 87%
Market capitalization -- NRXP: $56.36M vs. OSTX: $70.01M
NRXP [@Biotechnology] is valued at $56.36M. OSTX’s [@Biotechnology] market capitalization is $70.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NRXP’s FA Score shows that 0 FA rating(s) are green whileOSTX’s FA Score has 1 green FA rating(s).

  • NRXP’s FA Score: 0 green, 5 red.
  • OSTX’s FA Score: 1 green, 4 red.
According to our system of comparison, OSTX is a better buy in the long-term than NRXP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NRXP’s TA Score shows that 6 TA indicator(s) are bullish while OSTX’s TA Score has 5 bullish TA indicator(s).

  • NRXP’s TA Score: 6 bullish, 4 bearish.
  • OSTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NRXP is a better buy in the short-term than OSTX.

Price Growth

NRXP (@Biotechnology) experienced а +17.48% price change this week, while OSTX (@Biotechnology) price change was +19.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.94%. For the same industry, the average monthly price growth was +21.39%, and the average quarterly price growth was +21.23%.

Reported Earning Dates

OSTX is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+5.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OSTX($70M) has a higher market cap than NRXP($56.4M). NRXP YTD gains are higher at: 31.364 vs. OSTX (-51.869). OSTX has higher annual earnings (EBITDA): -10.07M vs. NRXP (-24.11M). NRXP has more cash in the bank: 5.55M vs. OSTX (2.97M). NRXP (0) and OSTX (0) have equivalent revenues.
NRXPOSTXNRXP / OSTX
Capitalization56.4M70M81%
EBITDA-24.11M-10.07M239%
Gain YTD31.364-51.869-60%
P/E Ratio0.36N/A-
Revenue00-
Total Cash5.55M2.97M187%
Total Debt8.4MN/A-
FUNDAMENTALS RATINGS
NRXP: Fundamental Ratings
NRXP
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
93
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NRXPOSTX
RSI
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 4 days ago
90%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OSTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ENNPF17.80N/A
N/A
Enbridge Inc.
FARYF0.25N/A
N/A
Far LTD
HNLGF1.78N/A
N/A
Hang Lung Group Ltd.
HAGHY49.51-0.48
-0.95%
HENSOLDT AG
TUWOY0.07N/A
-4.67%
Tullow Oil Plc.

NRXP and

Correlation & Price change

A.I.dvisor indicates that over the last year, NRXP has been closely correlated with CDTX. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if NRXP jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRXP
1D Price
Change %
NRXP100%
+8.24%
CDTX - NRXP
85%
Closely correlated
+2.62%
NBY - NRXP
84%
Closely correlated
+2.10%
NCNA - NRXP
84%
Closely correlated
-10.12%
RNAC - NRXP
83%
Closely correlated
-0.87%
ALLR - NRXP
83%
Closely correlated
-2.22%
More

OSTX and

Correlation & Price change

A.I.dvisor tells us that OSTX and CRGX have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OSTX and CRGX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OSTX
1D Price
Change %
OSTX100%
-4.19%
CRGX - OSTX
25%
Poorly correlated
+1.79%
XNCR - OSTX
23%
Poorly correlated
+0.39%
NRXP - OSTX
22%
Poorly correlated
+8.24%
GLTO - OSTX
20%
Poorly correlated
-1.55%
NAUT - OSTX
20%
Poorly correlated
-1.27%
More